Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Go back to Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study| (NASDAQ: LEXX) | Delayed: 5.67 +0.05 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.62 | 52 Week High | $ | |||
| Open | $5.68 | 52 Week Low | $ | |||
| Day High | $6.09 | P/E | N/A | |||
| Day Low | $5.23 | EPS | $ | |||
| Volume | 72,233 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 34,751 | |||||
